Seems like with a daily risk of 0.03% per day.... Or 3/10000 is so low that for most post operative patients.... The risk of bleeding is much higher than risk of stroke.
The original question came because we have had a run of patients that were restarting on anticoagulation for atrial fibrillation before 7 days post operatively which subsequently developed complications (post op thyroidectomy who developed neck hematoma and needed re-op, a post operative whipple who bled a week out once lovenox full dose starting, etc).
What seems to be happening is the cardiologist/medicine consultants say "restart anti-coagulation as soon as possible" and the surgeons, who have no idea how low the daily risk of them holding off.... Feel obligated to restart soonish.
Now it seems this is the fault of both sets of doctors. On the one hand the generic comment "restart as soon as possible" is, superficially, an okay statement. But it negates the recognition that this treatment is VERY different than attenuating the risk for much more concerning pathologies like mechanical valves, recently placed cardiac drug eluding stents, etc.
I just wish if people reconciled the massive difference in stroke risk when anti-coagulation is held for atrial fibrillation compared to a recent drug eliding stent, practices may be different.
What are your thoughts?